封面
市场调查报告书
商品编码
1465542

血液透析设备市场 - 副产品(血液透析机、消耗品)、最终用途(医院、透析中心、家庭护理设施) - 全球预测,2024 年 - 2032 年

Hemodialysis Equipment Market - By Product (Hemodialysis Machines, Consumables), End-use (Hospitals, Dialysis Centers, Homecare Settings) - Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 184 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于高血压、糖尿病和人口老化等因素导致 ESRD(末期肾病)病例增加,预计血液透析设备市场从 2024 年到 2032 年的复合年增长率将达到 6.4%。根据国际肾臟病学会的数据,到 2023 年,全球约有 8.5 亿人患有慢性肾臟病。此外,技术的进步,例如便携式和家用血液透析机的开发,提高了患者的便利性和可及性。

此外,人们越来越认识到早期发现和治疗肾臟疾病的好处,加上医疗支出不断增加,正在促进血液透析设备的使用。医疗保健提供者越来越多地投资于创新解决方案,以满足对肾臟替代疗法不断增长的需求。此外,主要参与者在产品开发和地理扩张方面的策略合作和伙伴关係将促进市场成长。

血液透析设备产业根据产品、最终用途和地区进行分类

从产品来看,血液透析机领域的市场价值在2024年至2032年间将录得6.5%的成长率。 。此外,旨在改善透析服务机会的优惠报销政策和措施正在刺激血液透析机的使用,特别是在新兴经济体。

由于肾臟疾病盛行率不断上升,预计到 2032 年,透析中心最终用途领域的血液透析设备市场复合年增长率将达到 6.2%。透析中心需要一系列血液透析设备,包括机器、透析器和水处理系统,以便为患者提供高品质的肾臟替代疗法。此外,数位监控系统和远端患者管理解决方案的整合正在提高透析中心运作的效率和有效性,进一步推动对现代血液透析设备的需求。

由于人口迅速老化,亚太地区血液透析设备产业到 2032 年将以 6.9% 的复合年增长率实现显着增长。不断增长的医疗保健支出,加上政府为提高肾臟替代治疗的可及性而采取的倡议,正在推动中国、印度和日本等国家对血液透析设备的需求。此外,血液透析机的技术进步有助于满足特定需求,例如经济高效和紧凑的设计。此外,国际和本地参与者之间开发创新解决方案和扩大分销网络的策略合作将进一步推动区域市场的成长。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 肾臟疾病盛行率增加
      • 增加研发投入
      • 血液透析设备的技术进步
      • 老年人口基数不断增加
    • 产业陷阱与挑战
      • 严格的监管场景
      • 设备成本高
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场估计与预测:按产品分类,2018 年 - 2032 年

  • 主要趋势
  • 血液透析机
    • 中心血液透析机
    • 家用血液透析机
  • 耗材
    • 透析器
    • 透析液
    • 接入产品
    • 其他消耗品

第 6 章:市场估计与预测:依最终用途,2018 - 2032 年

  • 主要趋势
  • 医院
  • 透析中心
  • 家庭护理设置
  • 其他最终用户

第 7 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 8 章:公司简介

  • Asahi Kasei Corporation.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Diaverum Holding AB
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Nipro Corporation
  • Nikkiso Co., Ltd
  • Rockwell Medical Technologies Inc.
  • Toray Industries, Inc.
简介目录
Product Code: 8038

Hemodialysis equipment market is estimated to record 6.4% CAGR from 2024 to 2032, driven by the rise in ESRD (end-stage renal disease) cases, attributed to factors, such as hypertension, diabetes, and aging population. As per the International Society of Nephrology, in 2023, around 850 million people suffered from chronic kidney diseases globally. Moreover, advancements in technology, such as the development of portable and home hemodialysis machines are enhancing patient convenience and accessibility.

Furthermore, the growing awareness about the benefits of early detection and treatment of kidney diseases coupled with rising healthcare expenditure are fostering the use of hemodialysis equipment. Healthcare providers are increasingly investing in innovative solutions to cater to the escalating demand for renal replacement therapies. Additionally, strategic collaborations and partnerships among key players for product developments and geographic expansion will bolster the market growth.

The hemodialysis equipment industry is classified on the basis of product, end-use and region

Based on product, the market value from the hemodialysis machines segment will record a 6.5% growth rate between 2024 and 2032. This is favored by technological advancements in the machines, such as the integration of touchscreen interfaces, improved monitoring capabilities, and enhanced automation features. Furthermore, favorable reimbursement policies and initiatives aimed at improving access to dialysis services are stimulating the uptake of hemodialysis machines, particularly in emerging economies.

Hemodialysis equipment market from the dialysis centers end-use segment is expected to witness a 6.2% CAGR till 2032, backed by the increasing prevalence of kidney diseases. Dialysis centers require a range of hemodialysis equipment, including machines, dialyzers, and water treatment systems, to deliver high-quality renal replacement therapy to patients. Additionally, the integration of digital monitoring systems and remote patient management solutions are enhancing the efficiency and effectiveness of dialysis center operations, further fueling the demand for modern hemodialysis equipment.

Asia Pacific hemodialysis equipment industry will record notable growth at 6.9% CAGR through 2032, attributed to the rapidly aging population. Rising healthcare expenditure, coupled with government initiatives to enhance access to renal replacement therapy, is fueling the demand for hemodialysis equipment in countries like China, India, and Japan. Furthermore, technological advancements in hemodialysis machines are helping to meet specific needs, such as cost-effective and compact designs. Additionally, strategic collaborations between international and local players to develop innovative solutions and expand distribution networks will further boost the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast calculations
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of kidney diseases
      • 3.2.1.2 Increased R&D investments
      • 3.2.1.3 Technological advancements in hemodialysis equipment
      • 3.2.1.4 Growing geriatric population base
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory scenario
      • 3.2.2.2 High cost of devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemodialysis machines
    • 5.2.1 In-center hemodialysis machine
    • 5.2.2 Home-based hemodialysis machine
  • 5.3 Consumables
    • 5.3.1 Dialyzers
    • 5.3.2 Dialysate
    • 5.3.3 Access products
    • 5.3.4 Other consumables

Chapter 6 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Dialysis centers
  • 6.4 Homecare settings
  • 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Asahi Kasei Corporation.
  • 8.2 Baxter International Inc.
  • 8.3 B. Braun Melsungen AG
  • 8.4 Diaverum Holding AB
  • 8.5 DaVita Inc.
  • 8.6 Fresenius Medical Care AG & Co. KGaA
  • 8.7 Nipro Corporation
  • 8.8 Nikkiso Co., Ltd
  • 8.9 Rockwell Medical Technologies Inc.
  • 8.10 Toray Industries, Inc.